Tatoos and permanent makeup all contain a combination of several ingredients and more than 100 different colorants and 100 additives are currently in use. The pigments used are not specifically produced for tattoo and permanent makeup applications, and generally contain impurities. Over 80% of the colorants in use are organic chemicals and more than 60% of them are a certain type of pigments, known as azo-pigments, some of which can release carcinogenic aromatic amines. This can be the result of a degradation process in the skin, particularly under solar/ultra violet radiation exposure or laser irradiation.
There is no systematic data gathering for adverse effects on human health, so the actual prevalence of tattoo complications (mainly of dermatological nature) is not well known. Most complaints are transient and inherent to the wound healing process. However, bacterial infections may happen in up to 5% of people with tattoos, especially when the tattooing was carried out in unhygienic settings. Adverse health effects linked to the application but also increasingly to the removal of tattoos are reported. The risk of (skin) cancer from tattoo procedures has been neither proved nor excluded.
Measures that could contribute to enhancing the safety of tattoos would be Good Manufacturing Practices for manufacturing tattoo/permanent makeup inks, guidelines for their risk assessment, as well as harmonised analytical methods and information campaigns on risks for both tattooists and potential clients.
The JRC study, carried out on behalf of the Commission’s Directorate-General Justice and Consumers, aims to provide the scientific evidence needed to decide if EU measures are necessary to ensure the safety of inks and processes used in tattoos and (semi)permanent makeup.
The findings of this JRC report, as well as two previous reports, on trends in tattoo practices and on legislative framework and analytical methods, will be used by the European Chemicals Agency (ECHA) to prepare a possible restriction proposal in the framework of the REACH regulation following a request from the European Commission. REACH refers to ‘Registration, Evaluation, Authorisation and Restriction of Chemicals’ and is a EU Regulation, adopted to improve the protection of human health and the environment from the risks that can be posed by chemicals, while enhancing the competitiveness of the EU chemicals industry.
Source: Medical news today